Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Treatment of Post-SCI Hypotension
NCT02919917Phase 3Completed
- Sponsor
- James J. Peters Veterans Affairs Medical Center
- Start
- Jun 2017
- Primary completion
- Sep 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of midodrine in orthostatic hypotension (OH) (2 arms), sponsored by James J. Peters Veterans Affairs Medical Center. Primary endpoints: Affected Therapy Sessions and Systolic Blood Pressure. Started Jun 2017; status: completed.
02
Drugs
midodrine
03
Conditions
orthostatic hypotension (OH)
Beyond the preview
Go deeper on NCT02919917.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02919917.